You are here

Docket Number 3157

Received: 
Wednesday, June 15, 2016
Commodity: 
Potassium Chloride Powder Products
Investigation Number: 
337-TA-1013
Filed By: 
David A. Hickerson
Firm/Organization: 
Foley & Lardner LLP
Behalf Of: 
Lehigh Valley Technologies, Inc., Endo Global Ventures, Endo Ventures Limited and Generics Bidco I, LLC (d/b/a Qualitest Pharmaceuticals and Par Pharmaceutical)
Confidential: 
Yes
Country: 
none
Description: 
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Potassium Chloride Powder Products. The proposed respondents are: Viva Pharmaceutical Inc., Canada; Virtus Pharmaceuticals, LLC, Tampa, Florida; and Virtus Pharmaceuticals OPCO II, LLC, Nashville, Tennessee.